Chronic Kidney Disease, Hyperkalemia and Echocardiographic Changes
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSaglik Bilimleri Universitesi
About this trial
Patients with CKD ( eGFR \< \<60 mL/min/1,73 m2) presenting to emergency department with isolated hyperkalemia will be study population. Pre and post treatment ECG and echocardiographic findings will be recorded. Investigator will not intervene with the treatment decision of responsible physician and will not delay any intervetion or treatment for the sake of study.
Data will be compared in terms of ECHO and ECG findings depending on hyperkalemia level and response to treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 18 years old
Chronic kidney disease patients with eGFR < 60 mL/min/1.73 m²
Patients with hyperkalemia detected in the emergency department
Patients willing to participate in the study and who sign the consent form
Disqualifiers
Patients under 18 years old
Patients who do not wish to participate in the study
Patients without chronic kidney damage
Patients without detected hyperkalemia
Trial population
Patient with chronic kidney disease presenting to emergency department and having isolated hyperkalemia with or without ECG changes
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
40 Participants
are grouped into 1 trial groupGroup A: Hyperkalemia
Trial outcomes
Primary outcomes
1
ECHO changes
Describing echocardiograhic (ECHO) changes of isolated hyperkalemia in patients with chronic kidney disease (CKD)
Time frame
from enrollment to the end of follow up duration of 30 daysSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov